Development of diagnostics in the search for an explanation of aerotoxic syndrome

Analytical Biochemistry

Volumn 404, Issue 1, 2010, Pages 64-74

  Schopfer, Lawrence M ^a   Furlong, Clement E ^b   Lockridge, Oksana ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Aerotoxic syndrome; Butyrylcholinesterase; CBDP; Mass spectrometry; Organophosphorus agent; Serum albumin; Tyrosine

Indexed keywords

MASS SPECTROMETRY;

AEROTOXIC SYNDROME; BUTYRYLCHOLINESTERASE; CBDP; SERUM ALBUMIN; TYROSINE;

AMINO ACIDS;

2 (ORTHO CRESYL) 4H 1,3,2 BENZODIOXAPHOSPHORAN 2 ONE; BENZODIOXAN DERIVATIVE; TRICRESYL PHOSPHATE; UNCLASSIFIED DRUG; 2-(2-CRESYL)-4H-1-3-2-BENZODIOXAPHOSPHORIN-2-OXIDE; AIR POLLUTANT; BIOLOGICAL MARKER; CHOLINESTERASE; ORGANOPHOSPHORUS COMPOUND; SERUM ALBUMIN; TYROSINE;

AEROTOXIC SYNDROME; AFFINITY CHROMATOGRAPHY; AIRCRAFT; ALKYLATION; ARTICLE; CHEMICAL ANALYSIS; CHEMICAL STRUCTURE; COVALENT BOND; CYCLIZATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTOXICATION; MASS SPECTROMETRY; PHOSPHORYLATION; PRIORITY JOURNAL; AIR POLLUTANT; CHEMISTRY; ELECTROSPRAY MASS SPECTROMETRY; PROCEDURES; TOXICITY;

AIR POLLUTANTS; AIRCRAFT; BIOLOGICAL MARKERS; BUTYRYLCHOLINESTERASE; HUMANS; ORGANOPHOSPHORUS COMPOUNDS; SERUM ALBUMIN; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TYROSINE;

EID: 77954085622     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2010.04.032     Document Type: Article

References (27)

1. De Nola G., Kibby J., Mazurek W. Determination of ortho-cresyl phosphate isomers of tricresyl phosphate used in aircraft turbine engine oils by gas chromatography and mass spectrometry. J. Chromatogr. A 2008, 1200:211-216.
2. Winder C., Balouet J.C. The toxicity of commercial jet oils. Environ. Res. 2002, 89:146-164.
3. van Netten C., Leung V. Hydraulic fluids and jet engine oil: pyrolysis and aircraft air quality. Arch. Environ. Health 2001, 56:181-186.
4. Aldridge W.N. Tricresyl phosphates and cholinesterase. Biochem. J. 1954, 56:185-189.
5. Henschler D. Tricresylphosphate poisoning: experimental clarification of problems of etiology and pathogenesis. Klin. Wochenschr. 1958, 36:663-674.
6. Kidd J.G., Langworthy O.R. Jake paralysis: paralysis following the ingestion of Jamaica ginger extract adulterated with tri-ortho-cresyl phosphate. Bull. Johns Hopkins Hosp. 1933, 52:39-65.
7. Morgan J.P. The Jamaica ginger paralysis. JAMA 1982, 248:1864-1867.
8. Smith H.V., Spalding J.M. Outbreak of paralysis in Morocco due to ortho-cresyl phosphate poisoning. Lancet 1959, 2:1019-1021.
9. Wang D., Tao Y., Li Z. Toxic polyneuropathy due to flour contaminated with tricresyl phosphate in China. J. Toxicol. Clin. Toxicol. 1995, 33:373-374.
10. National Institute for Occupational Safety and Health, International Chemical Safety Card no. 0961 validated April 5, 2006, including the associated IDLH (immediately dangerous to life and health) documentation for CAS 78-30-8 (2006).
11. Casida J.E. Specificity of substituted phenyl phosphorus compounds for esterase inhibition in mice. Biochem. Pharmacol. 1961, 5:332-342.
12. Ding S.J., Carr J., Carlson J.E., Tong L., Xue W., Li Y., Schopfer L.M., Li B., Nachon F., Asojo O., Thompson C.M., Hinrichs S.H., Masson P., Lockridge O. Five tyrosines and two serines in human albumin are labeled by the organophosphorus agent FP-biotin. Chem. Res. Toxicol. 2008, 21:1787-1794.
13. B. Li, I. Ricordel, L. M. Schopfer, F. Baud, B. Megarbane, P. Masson, O. Lockridge, Dichlorvos, chlorpyrifos oxon, and aldicarb adducts of butyrylcholinesterase detected by mass spectrometry in human plasma following deliberate overdose, J. Appl. Toxicol. (in press).
14. B. Li, I. Ricordel, L. M. Schopfer, F. Baud, B. Megarbane, F. Nachon, P. Masson, O. Lockridge, Detection of adduct on tyrosine 411 of albumin in humans poisoned by dichlorvos, Toxicol. Sci. (in press).
15. Fidder A., Hulst A.G., Noort D., de Ruiter R., van der Schans M.J., Benschop H.P., Langenberg J.P. Retrospective detection of exposure to organophosphorus anti-cholinesterases: Mass spectrometric analysis of phosphylated human butyrylcholinesterase. Chem. Res. Toxicol. 2002, 15:582-590.
16. Eto M., Casida J.E., Eto T. Hydroxylation and cyclization reactions involved in the metabolism of tri-o-cresyl phosphate. Biochem. Pharmacol. 1962, 11:337-352.
17. Casida J.E., Eto M., Baron R.L. Biological activity of a tri-o-cresyl phosphate metabolite. Nature 1961, 191:1396-1397.
18. Eto M., Oshima Y., Casida J.E. Plasma albumin as a catalyst in cyclization of diaryl o-(α-hydroxy)tolyl phosphates. Biochem. Pharmacol. 1967, 16:295-308.
19. Toia R.F., Casida J.E. Phosphorylation, " aging" , and possible alkylation reactions of saligenin cyclic phosphorus esters with α-chymotrypsin. Biochem. Pharmacol. 1979, 28:211-216.
20. Casida J.E., Quistad G.B. Organophosphate toxicology: safety aspects of nonacetylcholinesterase secondary targets. Chem. Res. Toxicol. 2004, 17:983-998.
21. Lockridge O., Schopfer L.M., Winger G., Woods J.H. Large scale purification of butyrylcholinesterase from human plasma suitable for injection into monkeys: a potential new therapeutic for protection against cocaine and nerve agent toxicity. J. Med. Chem. Biol. Radiol. Def. 2005, 3.
22. Schopfer L.M., Grigoryan H., Li B., Nachon F., Masson P., Lockridge O. Mass spectral characterization of organophosphate-labeled, tyrosine-containing peptides: characteristic mass fragments and a new binding motif for organophosphates. J. Chromatogr. B 2010, 878:1297-1311.
23. Kovach I.M. Stereochemistry and secondary reactions in the irreversible inhibition of serine hydrolases by organophosphorus compounds. J. Phys. Org. Chem. 2004, 17:602-614.
24. Li B., Nachon F., Froment M.T., Verdier L., Debouzy J.C., Brasme B., Gillon E., Schopfer L.M., Lockridge O., Masson P. Binding and hydrolysis of soman by human serum albumin. Chem. Res. Toxicol. 2008, 21:421-431.
25. Ashbolt R.F., Rydon H.N. The action of diisopropyl phosphorofluoridate, and other anticholinesterases on amino acids. Biochem. J. 1957, 66:237-242.
26. Tang J., Cao Y., Rose R.L., Brimfield A.A., Dai D., Goldstein J.A., Hodgson E. Metabolism of chlorpyrifos by human cytochrome P450 isoforms and human, mouse, and rat liver microsomes. Drug Metab. Dispos. 2001, 29:1201-1204.
27. Jiang W., Duysen E.G., Hansen H., Shlyakhtenko L., Schopfer L.M., Lockridge O. Mice treated with chlorpyrifos or chlorpyrifos oxon have organophosphorylated tubulin in the brain and disrupted microtubule structures, suggesting a role for tubulin in neurotoxicity associated with exposure to organophosphorus agents. Toxicol. Sci. 2010, 115:183-193.